Please login to the form below

Not currently logged in
Email:
Password:

Epidarex

This page shows the latest Epidarex news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Charity criticises NHSE and Vertex over Orkambi access, Sema scores again, NodThera launched

Daily Brief: Charity criticises NHSE and Vertex over Orkambi access, Sema scores again, NodThera launched

The fundraising was co-led by leading healthcare investors Sofinnova Partners and 5AM Ventures, with Epidarex Capital and F-Prime Capital Partners also taking part.

Latest news

  • Lilly invests in UK life sciences via biotech fund Lilly invests in UK life sciences via biotech fund

    The fund will also tap into Epidarex' links with Scottish universities - including Edinburgh, Glasgow and Aberdeen - and try to encourage the creation of spin-out companies, said the investors. . ... The completion of our fund is a significant

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • IGEM Therapeutics appoints Dr Tim Wilson as CEO IGEM Therapeutics appoints Dr Tim Wilson as CEO

    has raised £2m from Epidarex Capital, in order to progress its pipeline of IgE antibody drug candidates. ... Dr Peter Finan, venture partner and Epidarex Capital, said: “We are very pleased to have been able to recruit Dr Tim Wilson to lead IGEM as CEO

  • Caldan Therapeutics appoints CEO Caldan Therapeutics appoints CEO

    Dr Liz Roper, partner at Epidarex Capital, which backs Caldan Therapeutics, said: “We are delighted to welcome Mark on board to lead Caldan Therapeutics moving forward.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....